Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduce...
10 Health Care Stocks With Whale Alerts In Today’s Session
Ionis Maintains Buy Rating as Olezarsen’s sHTG Profile Outshines Rival; $86 Price Target Reaffirmed
Pre-market hot trades in US stocks: Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%
This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Ionis to hold second quarter 2026 financial results webcast | IONS Stock News
Biogen Slumps As Alzheimer's Study Leaves 'More Questions Than Answers'